Top 5 Blue Chip Stocks To Invest In 2019

During these busy times, it pays to stay on top of the latest profit opportunities, and today’s blog post is a great place to start.

After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 82 big blue chips.

Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

This Week’s Ratings Changes:

Top 5 Blue Chip Stocks To Invest In 2019: Chemical Financial Corporation(CHFC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Dupont Capital Management Corp purchased a new stake in Chemical Financial Co. (NASDAQ:CHFC) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 7,013 shares of the bank’s stock, valued at approximately $257,000.

  • [By Joseph Griffin]

    Media stories about Chemical Financial (NASDAQ:CHFC) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chemical Financial earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned news articles about the bank an impact score of 45.6707430515367 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Ethan Ryder]

    Chemical Financial (NASDAQ:CHFC) was downgraded by ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued on Tuesday.

Top 5 Blue Chip Stocks To Invest In 2019: Energy Focus, Inc.(EFOI)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Energy Focus Inc (NASDAQ:EFOI) have been assigned an average recommendation of “Hold” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $4.00.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Energy Focus (EFOI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Invest In 2019: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Apogee Enterprises Inc (NASDAQ:APOG) have been given a consensus rating of “Hold” by the seven research firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $53.50.

  • [By Garrett Baldwin]

    The price of Bitcoin surged more than 17% to top $8,000 in a rapid move that surprised many investors this morning. The sudden rally appears to be the result of a short squeeze, according to CNBC contributor Brian Kelly. This means that investors who had been betting on a decline in the price of the world’s largest cryptocurrency had been forced to jump back and buy the currency again. A lot of people have been betting on a decline in the price of Bitcoin heading toward the April 17 tax deadline. The expectation is that many people will need to sell their Bitcoin in order to raise cash to meet tax obligations. Here’s our latest daily insight on why the Bitcoin bear market may end very soon.
    Markets gains have been capped by concerns about the latest news out of the Federal Reserve. On Wednesday, minutes from the Fed’s most recent meeting indicated that policy makers are prepared to raise interest rates several more times in the coming months in order to stave off concerns about inflation.
    Four Stocks to Watch Today: BLK, FB, DAL
    Shares of BlackRock Inc. (NYSE: BLK) are on the move after the company reported earnings before the bell. The firm reported earnings per share (EPS) of $6.70. Analysts projected the firm would report EPS of $6.45 on top of $3.28 billion in revenue. The firm topped revenue expectations. The firm noted that an increase in its consulting fees and the recent tax reform bill helped bolster its profitability by 27%.
    The stock of Facebook Inc. (Nasdaq: FB) has climbed more than 6% since Tuesday. Investors cheered the testimony of CEO Mark Zuckerberg, who appeared before Congress for two days to discuss his company’s privacy policies. The CEO and his firm have been under intense scrutiny since news broke that 87 million user accounts had been accessed without permission by consulting firm Cambridge Analytica during the 2016 election season. The firm had ties to President Trump’s campaign.
    Delta Air Lines Inc. (NYSE: DAL) reported ea

  • [By Max Byerly]

    BidaskClub upgraded shares of Apogee Enterprises (NASDAQ:APOG) from a buy rating to a strong-buy rating in a research report sent to investors on Wednesday morning.

  • [By Dan Caplinger]

    Apogee Enterprises (NASDAQ:APOG) has benefited greatly from the rebound in construction activity recently, which has helped the architectural glass and framing specialist bounce back from difficult conditions in past years. Yet despite solid business conditions throughout 2017, Apogee stock has struggled as investors seemed to question whether its growth path was sustainable.

  • [By Motley Fool Staff]

    Apogee Enterprises (NASDAQ:APOG) Q1 2019 Earnings Conference CallJun. 28, 2018 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Apogee Enterprises (APOG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Invest In 2019: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Curis alerts:

    $2.41 Million in Sales Expected for Curis, Inc. (CRIS) This Quarter (americanbankingnews.com) Curis Stock Scheduled to Reverse Split on Wednesday, May 30th (CRIS) (americanbankingnews.com) Zacks: Analysts Expect Curis, Inc. (CRIS) to Post -$0.09 Earnings Per Share (americanbankingnews.com) Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development (finance.yahoo.com) Is Curis, Inc. (CRIS) In Search of Footing? (nmsunews.com)

    Shares of Curis stock traded up $0.01 on Monday, hitting $0.45. The company had a trading volume of 1,290,968 shares, compared to its average volume of 1,462,753. The stock has a market capitalization of $74.57 million, a PE ratio of -1.25 and a beta of 1.29. Curis has a twelve month low of $0.41 and a twelve month high of $2.27. The company has a quick ratio of 3.60, a current ratio of 3.60 and a debt-to-equity ratio of 2.24.

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra

Top 5 Blue Chip Stocks To Invest In 2019: Capitol Federal Financial(CFFN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News headlines about Capitol Federal Financial (NASDAQ:CFFN) have trended positive on Thursday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Capitol Federal Financial earned a media sentiment score of 0.31 on Accern’s scale. Accern also assigned news coverage about the savings and loans company an impact score of 47.2593540313148 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Max Byerly]

    Dean Capital Investments Management LLC bought a new stake in Capitol Federal Financial, Inc. (NASDAQ:CFFN) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 42,438 shares of the savings and loans company’s stock, valued at approximately $558,000.

  • [By Joseph Griffin]

    BankUnited (NYSE: BKU) and Capitol Federal Financial (NASDAQ:CFFN) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

  • [By Joseph Griffin]

    People’s United Financial (NASDAQ: PBCT) and Capitol Federal Financial (NASDAQ:CFFN) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

  • [By Stephan Byrd]

    Capitol Federal Financial (NASDAQ: CFFN) and Northrim BanCorp (NASDAQ:NRIM) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends.

Leave a Reply

Your email address will not be published. Required fields are marked *